6CV-26604-64174
4 vaccinations
3 coded responses
33 check-ins
2 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 480 / MI
- Registered
- 2021-04-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-10
Registered in v-safe
-
2021-04-10
Dose 1 — Pfizer-BioNTech
- 2021-04-10
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-15
- 2021-04-16
- 2021-04-17
- 2021-04-24
-
2021-05-01
Dose 2 — Pfizer-BioNTech
- 2021-05-01
-
2021-05-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-05-04
- 2021-05-05
- 2021-05-06
- 2021-05-07
- 2021-05-08
- 2021-05-15
- 2021-05-24
- 2021-05-29
- 2021-06-05
-
2021-06-12
Survey response — day 42, dose 2MedDRA: Herpes zoster — Feeling: Poor · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: ShinglesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-12
Report sent to call center — day 42, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-22
-
2021-07-31
Survey response — 3 months, dose 2MedDRA: Herpes zoster — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: ShinglesMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-31
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-10-05
Dose 3 — Pfizer-BioNTech
- 2021-10-30
- 2021-11-03
- 2022-05-01
-
2022-09-09
Dose 4 — Pfizer-BioNTech
- 2022-09-21
- 2022-09-23
- 2022-10-02
- 2022-10-07
- 2022-10-14
- 2022-10-21
- 2022-12-11
-
2023-03-10
Survey response — 6 months, dose 4MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-03-10
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2023-03-13
- 2023-03-13
- 2023-03-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-10 | Pfizer-BioNTech | |
| 2 | 2021-05-01 | Pfizer-BioNTech | |
| 3 | 2021-10-05 | Pfizer-BioNTech | No |
| 4 | 2022-09-09 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-06-12 | Unsuccessful | |
| 2021-07-31 | Unsuccessful | |
| 2023-03-10 | Unsuccessful |
Free text
Release 9 — day 42, dose 2
Symptoms: Shingles
Release 9 — 3 months, dose 2
Symptoms: Shingles
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Herpes zoster | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release